NCT03732313 is a NA clinical trial of Central toenail resection in Ingrown Toenail, sponsored by Zagazig University.

Who is sponsoring NCT03732313?

NCT03732313 is sponsored by Zagazig University.

What drugs are being tested in NCT03732313?

Interventions in NCT03732313: Central toenail resection, Wedge toenail resection.

What condition does NCT03732313 study?

NCT03732313 studies Ingrown Toenail.

Is NCT03732313 still recruiting?

NCT03732313 is currently completed. Last updated 6 November 2018.

Last reviewed 2018-11-06 · How we verify

NCT03732313

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Altering Toenail Biomechanic in Managing Ingrown Toenail.

Completed NA Last updated 6 November 2018

What this trial tests

NA trial testing Central toenail resection in Ingrown Toenail in 10 participants. Completed in 1 July 2018.

Timeline

1 January 2017

Primary endpoint
1 January 2018

1 July 2018

Quick facts

Lead sponsor	Zagazig University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	10
Start date	1 January 2017
Primary completion	1 January 2018
Estimated completion	1 July 2018

Drugs / interventions tested

Central toenail resection
Wedge toenail resection

Conditions studied

Ingrown Toenail — all drugs for Ingrown Toenail →

Sponsor

Zagazig University

Who can join

Adults 10 to 35, any sex, with Ingrown Toenail. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ingrown toenail is commonly met in clinical practice.treatment may be non-operative and operative treatment.operative trestment depends on lateral wedge resection of the nail. The idea is to change toenail biomechanics by central toenail resection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A systematic review and meta-analysis of randomised controlled trials on surgical treatments for ingrown toenails part I: recurrence and relief of symptoms.
Exley V, Jones K, O'Carroll G, Watson J, et al · · 2023 · cited 13× · PMID 37301845 · DOI 10.1186/s13047-023-00631-1

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03732313 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 6 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03732313.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing